Topical rVA576 for Treatment of Atopic Keratoconjunctivitis
Clinical trial NCT04037891 · TERMINATED
Trial details
- NCT number
- NCT04037891
- Sponsor
- AKARI Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-04
- Primary completion
- 2020-04-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.